Happy with the progress to date and there's still another 11 patients results to come.
SDs also adds weight to the data big pharma look at, as shows to potentially slow down/stop the progression of this disease in front line patients. That in itself is a very big deal.
The expanded trial will almost certainly restart in Oct'24.
Holding.
Happy with the progress to date and there's still another...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.82M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.9¢ | $86.01K | 854.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 800000 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 43790 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| ATX (ASX) Chart |